-
-
Good Practice on the assessment of GMO-related aspects in the context of clinical trials with human cells genetically modified by means of viral vectors v5 15-09-2023 Good Practice on the assessment of GMO-related aspects in the context of clinical trials with human cells genetically modified by means of viral vectors v5 PDF | 471.66 kB
-
Common Application form for clinical research with human cells genetically modified by means of viral vectors v5 15-09-2023 Common Application form for clinical research with human cells genetically modified by means of viral vectors v5 DOCX | 30.3 kB
-
10-2021 Guidance document VOV art 39b gm-cells LV-RV 14-10-2021 10-2021 Guidance document VOV art 39b gm-cells LV-RV PDF | 238.45 kB
-
2020-07-23 Guidance document gm-cells - Netherlands _V1.1 14-10-2021 2020-07-23 Guidance document gm-cells - Netherlands _V1.1 PDF | 286.57 kB
-
Gestandaardiseerde MRB VOV gm cellen zonder viruspartikels 14-10-2021 Gestandaardiseerde MRB VOV gm cellen zonder viruspartikels PDF | 455.4 kB
-
Gestandaardiseerde MRB VOV gm cellen LV met SIN deeltjes 14-10-2021 Gestandaardiseerde MRB VOV gm cellen LV met SIN deeltjes PDF | 529.1 kB
-
10-2021 Guidance document VOV art 39c gm-cells LV-SIN 14-10-2021 10-2021 Guidance document VOV art 39c gm-cells LV-SIN PDF | 237.28 kB
-
Beantwoording kamervragen 29-01-2019 15-02-2019 Beantwoording kamervragen 29-01-2019 PDF | 178.94 kB
-
Artikel Financieel Dagblad 18-12-2018 14-02-2019 Artikel Financieel Dagblad 18-12-2018 PDF | 687.69 kB